2024
DOI: 10.1016/j.jinorgbio.2023.112436
|View full text |Cite
|
Sign up to set email alerts
|

Lead to hit ruthenium-cyclopentadienyl anticancer compounds: Cytotoxicity against breast cancer cells, metabolic stability and metabolite profiling

Inês Maximiano,
Catarina Henriques,
Ricardo G. Teixeira
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…Similar results have been reported by Maximiano et al which investigated Phase I and II metabolites from ruthenium-cyclopentadienyl anticancer compounds (Scheme 2). 58…”
Section: Resultsmentioning
confidence: 99%
“…Similar results have been reported by Maximiano et al which investigated Phase I and II metabolites from ruthenium-cyclopentadienyl anticancer compounds (Scheme 2). 58…”
Section: Resultsmentioning
confidence: 99%